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Abstract
Background: In organisational theory there is an assumption that knowledge is used effectively in healthcare systems
that perform well. Actors in healthcare systems focus on managing knowledge of clinical processes like, for example,
clinical decision-making to improve patient care. We know little about connecting that knowledge to administrative
processes like high-risk medical device procurement. We analysed knowledge-related factors that influence
procurement and clinical procedures for orthopaedic medical devices in Mexico.
Methods: We based our qualitative study on 48 semi-structured interviews with various stakeholders in Mexico:
orthopaedic specialists, government officials, and social security system managers or administrators. We took a
knowledge-management related perspective (i) to analyse factors of managing knowledge of clinical procedures,
(ii) to assess the role of this knowledge and in relation to procurement of orthopaedic medical devices, and (iii)
to determine how to improve the situation.
Results: The results of this study are primarily relevant for Mexico but may also give impulsion to other health
systems with highly standardized procurement practices. We found that knowledge of clinical procedures in
orthopaedics is generated inconsistently and not always efficiently managed. Its support for procuring orthopaedic
medical devices is insufficient. Identified deficiencies: leaders who lack guidance and direction and thus use knowledge
poorly; failure to share knowledge; insufficiently defined formal structures and processes for collecting information and
making it available to actors of health system; lack of strategies to benefit from synergies created by information and
knowledge exchange. Many factors are related directly or indirectly to technological aspects, which are insufficiently
developed.
Conclusions: The content of this manuscript is novel as it analyses knowledge-related factors that influence procurement
of orthopaedic medical devices in Mexico. Based on our results we recommend that the procurement
mechanism should integrate knowledge from clinical procedures adequately in their decision-making. Without
strong guidance, organisational changes, and support by technological solutions to improve the generation
and management of knowledge, procurement processes for orthopaedic high-risk medical devices will remain
sub-optimal.
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Background
Healthcare systems are knowledge intensive environments
[1], where knowledge is a resource that must be efficiently
managed [2]. “Knowledge management” and the “system
thinking approach for systems’ knowledge” are systematic
approaches to identifying, capturing, developing, sharing,
and efficiently using knowledge [3, 4]. When healthcare
systems take these approaches, resources like knowledge
are used more efficiently [5–9]. Many knowledge frame-
works exist and they encompass different strategies [10]
to improve the systematic handling of knowledge and
potential knowledge within systems [11]. In healthcare
systems, stakeholders are concerned, for example, with
knowledge from clinical procedures. This knowledge is
created by processing different types of information,
and is derived from health data, as well as clinical data,
which includes (i) patient-related information, and (ii)
management information bearing on processes and out-
comes, such as the health status of a population [12].
In healthcare systems actors focus on managing know-
ledge of clinical procedures like clinical decision-making
to improve patient care [13–16] and activities to assure
healthcare worker and patient safety [17] (e.g. healthcare
working conditions that influence patient outcomes).
Using this knowledge effectively and efficiently requires
a substantial understanding of factors determining its man-
agement. In the general theory of knowledge management
the understanding of these factors (success or context fac-
tors) varies [10] but can be grouped along four dimensions.
These dimensions originated from a study comparing 160
knowledge management frameworks and describing these
dimensions as [11]: people (culture, people skills, and lead-
ership); organisation (processes and structures); manage-
ment (strategy, goals, and measurement); and, information
technology (infrastructure and applications).
In healthcare systems, knowledge of clinical processes
is an important resource across all stages of healthcare
delivery (clinician, care provider facility, social security
system, regulation, etc.) [18]. Understanding the manage-
ment of knowledge in the context of these dimensions and
across different stakeholders involved is necessary to solve
or prevent problems related to knowledge. For instance,
when organisations have to manage complaints and ad-
verse events of medical devices, they must consider more
than just organisational factors (processes, structures, etc.);
they also need to engage relevant stakeholders working out
strategies to prevent problems influencing clinical proce-
dures and affecting healthcare worker and patient safety
[17]. A complaint is a complication occurring in the course
of pre- or intra-operative procedures like, for example, the
positioning of a cap liner into the cap due to surgical tech-
nique, accompanying instruments or not visible damages
to the liner. An adverse event is an undesirable occurrence
for a patient and associated with the use of a medical
device that requires extra treatment or the removal of
an implanted medical device. For instance, a few years
ago several removals of specific breast implants (quality
of used material) and hip resurfacing implants (metal
debris damaging bone) were necessary [19, 20].
These products are high-risk medical devices (HRMD)
as they are highly regulated because they remain in the
patients’ body [21]. Examples for HRMDs are those used
in reconstructive surgery (breast implants, hip or knee
implants) or in the treatment of diseases (coronary stents).
Post-market surveillance plays an important role and en-
compasses the monitoring of the safety and effectiveness
of medical devices once they are on the market and used
in clinical settings [22]. This is an important function
within a healthcare system because HRMDs often remain
in the patient body. Healthcare systems and healthcare
providers must integrate all four dimensions into their
processes for capturing, developing, sharing, and effect-
ively using knowledge and for building administrative
frameworks [23, 24]. The contribution of information
technology in order to manage big data across different
levels of an organisation and healthcare system is
significant.
Adequately managed knowledge can support adminis-
trative processes, such as procurement [23]. Procurement
decision-making determines the devices and accompany-
ing services used for the treatment of patients, and is
knowledge-intensive [25]. Procuring HRMDs is a process
in which administrations or procurement agents use cer-
tain information from various parties to inform purchas-
ing decisions. Based on information it is the goal of
procurement to purchase goods that have an optimal
combination of high quality and low price [26]. The ways
the health system or social security system manages
knowledge will shape the way knowledge is used by pro-
curement. The administrator or agent may only use rigid
information about acquisition price and product specifica-
tions. Little is published about how knowledge of clinical
procedures or information related is used in relation to
administrative processes like procurement [26, 27].
Purpose
This research is part of a larger study to improve the un-
derstanding of the connection between procurement
processes for orthopaedic HRMDs in Mexico and clin-
ical procedures. In our previous study we observed that
in Mexico, mutual knowledge support (e.g. use of know-
ledge from arthroplasty registries) does not adequately
benefit procurement and clinical procedures of ortho-
paedic HRMDs. In Mexico, orthopaedic speciality belongs
to a concept of high level care attention and studies re-
ported that high level care attention is still in need of be-
ing strengthened [28]. The role played by procurement is
important because it provides clinicians with products
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and services. Previous research about public procurement
in Mexico focused on one of the social security institutes
providing an action plan for procurement officers, infor-
mation systems and supplier performance [29]. The aim
of our study is to analyse knowledge-related factors that
influence procurement of orthopaedic HRMDs in Mexico
and is governed by three objectives:
 Analyse factors of managing knowledge of clinical
procedures.
 Assess the role of this knowledge and in relation to
procurement of orthopaedic medical devices.
 Determine opportunities to improve the situation.
Methods
Study framework
Our research approach is based on a working framework
presented in Fig. 1, which is guided by two considerations
(i) procurement supports healthcare delivery and (ii) pro-
curement decision-making is knowledge sensitive.
First, we defined three healthcare delivery levels based
on the healthcare delivery model [30]: 1) macro (norma-
tive and policy mechanism); 2) meso (insurance system
& care provider facility); and, 3) micro (orthopaedic spe-
cialist and patient). Differentiating between these levels
is a crucial aspect of our research because public pro-
curement in Mexico and procurement decisions take
place at the meso level and not at the micro level. The
user is employed by the social security institute or min-
istry of health and has little autonomy during procure-
ment decision-making in respect to select a medical
device. This differs from other healthcare systems where
users are self-employed and the procurement mechan-
ism used by healthcare providers is independent of a
central purchasing function [31].
Second, we explain procurement based on the supply
link framework [32] and embed it along the three health-
care delivery levels. Procurement has three main actors:
supplier; procurement administration (purchaser); and,
internal customers (at the meso level) and users (at the
micro level). The interaction between the main actors is
shown by arrows and defined by (i) procurement (admin-
istrator or agent) and internal customer or user, and (ii)
procurement and supplier.
Third, we implemented the four knowledge manage-
ment dimensions [11] as the underlying concept of this
research approach and used them as orientation to ana-
lyse factors of managing knowledge (healthcare delivery
levels), to assess the role of knowledge from clinical pro-
cedures and in relation to procurement, and to identify
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findings having the ability to improve managing
knowledge.
Research method
The study was based on: (i) semi-structured interviews
with healthcare system stakeholders that represented macro
and meso levels (Group 1) to analyse how knowledge of
clinical procedures is managed among the knowledge man-
agement dimensions; and (ii) semi-structured interviews
with orthopaedic specialists who represent the micro level
(Group 2) to assess the role of knowledge from clinical pro-
cedures and in relation to procurement of orthopaedic
medical devices.
Rationale and validity of selected research method
We chose this approach because a quantitative approach
would not have given us enough data and because there
were so few prospective participants representing the
macro level and low-to-moderate number of prospective
participants representing the meso level.
To ensure validity and reliability we used several strat-
egies. First, during interviews we probed deeply to uncover
attitudes and open up new dimensions of a problem, and to
urge the stakeholder to describe their personal stake in the
process. Secondly, we triangulated data by defining a het-
erogeneous sample of stakeholders per group, and finally,
we used different interview guides (described in “data col-
lection”) that we pre-tested with few stakeholders from
Mexico.
Study population and participant selection
We interviewed 48 people and their composition is
presented in Table 1.
We identified and recruited participants for interviews
by (i) searching listings from the ministry of health and
industry for orthopaedic HRMDs, national academic ex-
perts, orthopaedic specialists, organisations, hospitals,
and institutions to identify potential interviewees and
(ii), we asked interviewees to recommend other stake-
holders. We based the sample on two criteria: (1) recruit
a heterogeneous sample across different stakeholders; and
(2) stakeholder being involved in or familiar with regula-
tions of medical devices, healthcare delivery of medical de-
vices, procurement and provision of medical devices in
Mexico. Sampling was rooted in a maximum variation
strategy [33, 34].
Data collection
The study was done in Mexico (Federal District and
State of Mexico). In this area the concentration of arthro-
plasty surgery across the country and the representation
of important government officials or key stakeholders of
healthcare providers is high. In Mexico, healthcare pro-
viders belong to an institution of the social security sector
(IMSS, ISSSTE, PEMEX, SEDENA, MARINA) that op-
erate on national level or to the ministry of health
(Seguro Popular de Salud, SEDS, Programa IMSS-O) [35].
We approached prospective interviewees between
February and March 2015 them by email or phone. Before
we invited them to an interview, the principal investigator
talked or wrote to them. Interviews took place at the office
Table 1 Extraction of interview guide questions
Group 1
Q1 On which organizational levels did Mexico achieve the required
quality assurance of already established
programs? Please explain how.
Q2 Which organizational level manifests the biggest barrier to
translate efforts of quality assurance into results?
Q3 Please describe your opinion on quality assurance and clinical
efficacy as contributing elements for the provision of medical
devices?.
Q4 Please describe how clinical data from the clinical practice level
is transferred back to the institutional level and how to the
national level?
Q5 Please describe the general consciousness of Mexican stakeholders
for the contribution of clinical evidence to their practice.
Q6 On which organizational levels or specific areas do you observe
weaknesses with regards to the consciousness?
Q7 Other countries say that it is a challenge to assure clinical
effectiveness of a medical device without the support of clinical
evidence? Only product safety is not sufficient for high-risk
medical devices. Based on which attempts or programs Mexico
tries to manage this situation.
Q8 Please describe what this means for the clinical practice and
outcome of the patient?
Q9 What actions are needed to improve this situation?
Group 2
Q1 What should be the relation of the orthopaedic surgeon and the
procurement of medical devices?
Q2 Please describe your role and knowledge in terms of the
procurement of medical devices?
Q3 Please describe what this means for yourself as surgeon who takes
over the responsibility for the clinical outcome of the patient?
Q4 In Mexico it is common practice to procure the majority of
medical devices through tenders and to award based on the
best price (respecting its listing in cuadro basico). What is your
experience on that?
Q5 Please describe how you perceive the outcome of the
procurement in terms of your clinical practice, the quality of
supplier service, and the intrinsic quality of the product?
Q6 How is clinical evidence and clinical data considered?
Q7 Please describe how long you can stick to the same implant
system in your public institution. Please distinct between trauma
and reconstruction devices?
Q8 Please describe what this means for the clinical practice and
outcome of the patient?
Q9 What actions are needed to improve this situation?
Q10 How do you currently obtain sustainable information on clinical
safety of a medical device?
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of the interviewee or at a place the interviewee selected
(e.g. conference room at work).
Interviews averaged 23 min (min = 18 min, max =
35 min). Interviewees had a choice of being interviewed
in Spanish or English. We used a file naming system and
anonymised interviewees by generating a list of archival
numbers. The principal investigator interviewed Group
1 participants and some Group 2 participants. A re-
search assistant interviewed the rest of the participants
from Group 2. Of the 48 interviews we conducted, 96 %
were face-to-face, and 4 % were phone interviews. We
audio recorded all interviews and transcribed them with
F5 software [36]. The principal investigator and two as-
sistants transcribed the interviews, and the principal in-
vestigator reviewed them again. The interviewers used
semi-structured interview guides including open-ended
questions that encouraged interview participants to
freely describe their opinions, thoughts and experiences
(Table 2). Participants were not compensated monetary
or otherwise.
Data analysis
We used our research approach model as a working
framework and opted to analyse the findings by the four
knowledge management dimensions because in this way,
we were able to describe the connectedness and inter-
action between the actors directly or indirectly involved
in procurement based on knowledge-related factors.
Other research approaches concerned with knowledge
management have been used as well but for different re-
search questions or approaches [37]. We iteratively ana-
lysed the content of all interviews [33] in MAXQDA
software version 11 [38] and to systematically inferred
interdependencies between the experiences and opinions
of stakeholders. First, we closely read each transcript
(data orientation) during initial coding. Second, we clus-
tered codes for similar themes and interrelated concepts
(data reduction). Third, we revised our list of themes,
improved codes and clustering if necessary, and clarified
ambiguous statements (data display). Lastly, we drew on
the themes we identified as deficiencies in the role and
management of knowledge (conclusion drawing). The
principal investigator analysed all data. Table 3 provides
an extraction of relevant statements.
Results
We found that knowledge is not necessarily generated
and managed efficiently enough to support procurement
of orthopaedic HRMDs. Generally, interviewees thought
this is a problem at the meso level and related to the di-
mensions “people” and “organisation”. Table 4 shows the
relevance of inadequately managed knowledge for all
four dimensions, at the macro, meso, and micro level.
The problems that were associated at the macro, meso
and micro levels, for the various knowledge-related fac-
tors, influence the role of knowledge from clinical proce-
dures and in relation to procurement of orthopaedic
HRMD. The results of our study show that this leads to
procurement decision-making that is insufficiently in-
formed by this knowledge and thus negatively influences
the provision and use of orthopaedic HRMDs. In Table 5
we summarize themes that describe these problems
based on the knowledge management dimensions and
the role of knowledge for procurement.
We divided our findings into three levels: (i) dimensions
of managing knowledge, (ii) the role of knowledge from
clinical procedures and in relation to procurement of
HRMD, and (iii) opportunities to improve the situation.
Dimensions of managing knowledge
People-related factors as barriers
One of the management theory expectations that can be
applied to this analysis is that if the culture of knowledge
is well established among the actors in a healthcare sys-
tem, knowledge can be adequately managed. However,
the results of this study show that knowledge is not ad-
equately managed at the meso level. To a lesser degree,
this is also true at the macro and micro levels. Many
stakeholders reported that there is not enough knowledge
leadership (e.g., guidance and direction in using know-
ledge) or competence to ensure knowledge will be effi-
ciently managed and used. The culture of knowledge
sharing and mutual learning is underdeveloped. We found
Table 2 Composition of participants
Expertise of participant Group 1 Group 2
n n
Total 25 23
Macro level
Regulation 4 0
Evidence synthesis 6 0
Orthopaedic association 3 0
Other expert 2 0
Meso level
Institution 4 0
Care provider facility 6 0
Micro level (orthopaedic specialist employed
by different institutes)
Social Security – IMSS 0 8
Social Security – ISSSTE 0 4
Social Security – PEMEX, SEDENA 0 3
Ministry of Health 0 8
IMSS Instituto Mexicano de Seguro Social (Mexican Institute of Social Security);
ISSSTE Instituto de Seguridad y Servicios Sociales de los Trabajadores del
Estado (Institute of Social Security and Services for State Workers); PEMEX
Petróleos Mexicanos (Mexican Petroleums); SEDENA Secretaría de la Defensa
Nacional (Secretariat of National Defense)
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Table 3 Extraction of relevant quotations
Themes Illustrative quotations Interviewee
People-related factors
Leadership “At the strategic or functional level they define and develop
and promote an idea and there is a disposition but after that
they are failing with the implementation.”
Group 1, Macro – International Expert
O.2._201503101730_MEX
“There was once, in the past two administrations, during
president Fox and president Calderon, very interesting quality
assurance strategies for all public institutions. Again, mostly
based on interpersonal quality and what the different institutions
and the different facilities… what they achieved in terms of
quality… depended a lot of the interest of particular clinical
groups.”
Group 1, Macro - Evidence synthesis
O.2._201502231200_MEX
“So in Mexico we have the problem that they don’t talk to each
other, they don’t understand each other and there is no
governance… so that the way how they solve the problem is
rather voluntary than an organizational or systemic matter.”
Group 1, Macro - Evidence synthesis
O.2._201502271200_MEX
Knowledge competence “The research culture here in Mexico is unfortunately very low
in comparison with the culture of other north American or
European countries…”
Group 1, Macro – Society
O.2._201503191830_MEX
“We still don't have a clear consciousness of the importance of
implementing quality assurance measures at the system level.
Quality concerns are concerned mostly of few groups within
institutions. So I think the big challenge, the first initial challenge
would be to develop a better consciousness of the importance
of continuous improvement. This is I think the main challenge.“
Group 1, Macro - Evidence synthesis
O.2._201502231200_MEX
“… sometimes we receive drugs of very good quality. But
sometimes we receive very bad quality because procurement
doesn’t focus on this… As long as a drug passed the requirements
of the health regulation of COFEPRIS there is a market…”
Group 1, Macro - Evidence synthesis
O.2._201502271200_MEX
Knowledge sharing “The doctors don’t always accept to provide this information.
Let’s think about health records. This is really a problem that the
doctors use them correctly… the information that is collected
is little reliable.”
Group 1, Macro – International Expert
O.2._201503101730_MEX
“The problem is that many don’t fill in the type of incident …
they don’t provide the name of the product. Therefore we
cannot make a match and process the complaint adequately…”
Group 1, Macro - Evidence synthesis
O.2._201503120900_MEX
“… nobody notifies about adverse reactions in this country…” Group 1, Macro - Evidence synthesis
O.2._201503091215_MEX
Mutual learning & skills “… they are still duplicating their efforts… but what is difficult
to change is the burocratic territory of each institute and there
is no incentive that could motivate them to focus on a common
purpose… an therefore they make what they can but not always
coordinated…”
Group 1, Macro – International Expert
O.2._201503101730_MEX
“I believe that we have to improve the quality … conceiving a
better interrelation between COFEPRIS and other federal units of
the secretariat of health.”
Group 1, Macro - Evidence synthesis
O.2._201503091215_MEX
“Because we don’t have, neither the resources and very probably
we don’t have the expertise needed to follow up and to organize
this kind of interventions.”
Group 1, Macro – Society
O.2._201503232000_MEX
Organization-related factors
National processes or structures “… apart of adverse events there is no intermediate information
available. So there is a lot of information that we loose… as
surgeon you are very limited with regards to access information…”
Group 1, Macro - Evidence synthesis
O.2._201503091215_MEX
“I believe the weakest area is the federal with COFEPRIS and the
strongest area is the Consejo de Salubridad General by means of
CENETEC which is step by step better involved in the evaluation
of medical technologies in a broad sense.”
Group 1, Meso - Institution
O.2._201503121800_MEX
“The problem is that no one makes a follow-up of the output of
results. Recently the secretariat of health has started to establish
an evaluation system of the performance of hospitals.”
Group 1, Macro – International Expert
O.2._201502240930_MEX
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Table 3 Extraction of relevant quotations (Continued)
Organizational processes or
structures
“They provide us with some type of report, they inform us in
general about number of prosthesis and patients… but we
don’t receive more information.”
Group 1, Meso – Institution
O.2._201502241600_MEX
“Further many federal units have different organizational
structures so that this makes the situation even worse… they
are heterogeneous so that en some units they are well
organized… but in others there doesn’t even exist such an
organization to adapt specific programmes…”
Group 1, Meso – Hospital
O.2._201503171700_MEX
“When you ask what is the number of intra hospital infections
that we have in Mexico nobody can provide you with a general
number… this is something that haven’t been established in
Mexico.”
Group 1, Macro – International Expert
O.2._201502240930_MEX
Management-related factors
Strategy “… programmes are established, they are effused like documents
to be used but rarely there is a control if these programmes are
realized… especially at the level of the secretariat of health…
There is a deficiency beginning at the central legal level up to
the state level where there are no adequate strategies to
implement a program to improve quality.”
Group 1, Meso – Hospital
O.2._201503171700_MEX
“The healthcare systems remains in the 21st century or migrated
back to the 20th century. What I want to say is that this system is
focusing to cover crises, episodes, but does not attend patients.”
Group 1, Macro - Evidence synthesis
O.2._201502271200_MEX
“…we are not using the information. We are collecting it and we
are organizing it, we have the conditions to use it at very different
levels, at the clinical level, at the top management level, but we
are not using it. ”
Group 1, Macro - Evidence synthesis
O.2._201502231200_MEX
Goal “The problem is that we are affiliating people and little by little
starting to guarantee regular access to comprehensive service.
Unfortunately the overall quality of the services that are being
provided is still very low especially at the ambulatory level. So, it
is good, that we are expanding coverage, but we need to expand
coverage with quality. If not, we are misspending the resources
we have mobilized. ”
Group 1, Macro - Evidence synthesis
O.2._201502231200_MEX
“Recently a new epoc has started where we can say what are the
palliative aspects that impacted … The famous collateral damages
or additional expenses, or I had to keep the patient hospitalised
longer because I could not operate him because the implant failed.”
Group 1, Meso – Hospital
O.2._201503130830_MEX
“If you go to a hospital and you want to certify it and you ask them
“Is there technical support for cardiotocography in the urgency
unit”, the answer may be yes but no one would ever ask if they also
know how to interpret the data.”
Group 1, Macro - Evidence synthesis
O.2._201502261200_MEX
Measurement “… the interesting thing is that there were no indicators for the
number of prescriptions that are aligned with the clinical guidelines.”
Group 1, Macro - Evidence synthesis
O.2._201503091215_MEX
“And so, here most time the evaluations stop evaluating the
existence of a product…”
Group 1, Macro - Evidence synthesis
O.2._201502261200_MEX
“…The infrastructure is limited and this is a serious problem
because there is interest … but also the money is an important
limitation…”
Group 1, Macro - Evidence synthesis
O.2._201502261115_MEX
Information technology-related factors
Infrastructure “… There are two problems that I can identify: One is the absence
of basic information systems … our information is in general not
systemised.”
Group 1, Macro – International Expert
O.2._201503101730_MEX
“Our registries are not complete, they are not reliable because not
everything is registered. Therefore it is an idea of numbers… but
a precise number requires a good registry with a very good
systematisation…”
Group 1, Meso - Hospital
O.2._201502251245_MEX
“…There might exist a lot of data in the different social security
systems or within the same system but they are not in a single
database”
Group 1, Macro - Evidence synthesis
O.2._201502250830_MEX
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a number of themes in the transcripts that described the
effect of people-related factors on knowledge manage-
ment, related to (i) leadership, (ii) knowledge competence,
(iii) knowledge sharing, and (iv) mutual learning.
Leaders direct the people who generate or manage
knowledge. Some stakeholders emphasized the strong
influence that key leaders have on directing and imple-
menting knowledge sharing initiatives, or on continuing
strategic quality assurance initiatives. Initiatives are often
discontinued or disrupted when the initiator moves on
to other tasks or passes the responsibility to others.
“[T]here was once, in the past two administrations…
very interesting quality assurance strategies for all
public institutions… what they achieved in terms of
quality… depended a lot of the interest of particular
clinical groups.”
(Group 1, O.2._201502231200_MEX)
Knowledge competence and sharing allow people to in-
tegrate knowledge effectively into their work. Some partic-
ipants mentioned this because in the area of clinical
research and investigation of orthopaedic speciality little is
published by Mexican orthopaedic specialists in scien-
tific journals and they related this to lack of interest, a
general weakness of the medical education system, or
the work framework for medical specialists in public
hospitals. For orthopaedic specialists in other countries,
the publication track record is important for their car-
eer paths.
“[T]here is little culture to publish scientific work… few
are really dedicated to this… because of a missing
focus during the medicine study and because of high
workload at the public institutes… and so it is difficult
to focus on research.”
(Group 1, O.2._201503191330_MEX)
Table 4 Relevance to strengthen management of knowledge
for all four dimensions and healthcare delivery levels
Dimension Macro level Meso level Micro level Total
People ++ +++ ++ ++(+)
Organisation ++ +++ ++ ++(+)
Management + ++ + +
Information technology + ++ ++ +(+)
Total +(+) ++(+) ++ ++
+++ very relevant ++ moderate relevant + relevant
Table 3 Extraction of relevant quotations (Continued)
Applications “And one of the more serious problems is the information system.
They are not based in patients, they are based in medical
consultations, in hospitalization…”
Group 1, Macro - Evidence synthesis
O.2._201502271200_MEX
“In some institutes … they do have an electronic health record,
but it is another deficiency that our country was not able so far
to consolidate the electronic health records on national level…”
Group 1, Macro - Evidence synthesis
O.2._201502261200_MEX
“… it is very difficult in the big hospitals and not all do have a
health record, there are big hospitals that have health records
but they don’t use it.”
Group 1, Macro - Society
O.2._201503191830_MEX
Factors related to the role of knowledge from clinical procedures
Relation of orthopaedic specialist
and procurement
“… because the procurement process here in … is rather
confidential, not all doctors participate, and sometimes it is very
superficial so that it is only about affirmative or negative, but …
often someone like a doctor doesn’t participate.”
Group 2, Micro - Social Security
O.2._201502241300_MEX
“They don’t take into consideration the surgeon to take decisions
because often the administrators decides and they buy things that
no one uses.”
Group 2, Micro – Ministry of Health
O.2._201503121730_MEX
“… this decides the head of the department together obviously
with the hospital director and … it is like a rather private situation…”
Group 2, Micro - Social Security
O.2._201503121830_MEX
Knowledge informed decision-making “…no because it is expected that they (COFEPRIS) have taken care
of it, they have test it and everything is good and this is not true,
many time not.”
Group 2, Micro - Social Security
O.2._201503241330_MEX
“… many times the decision-making is based on the material
type and economical aspects or the cost of these implants.”
Group 2, Micro - Social Security
O.2._201503181300_MEX
“No, I think it is very bad (information flow between micro and
meso level) what is exchanged between us because we have
requested a meeting between the people of the Seguro Popular
and us to explain which material is good and adequate for the
patients. But this has never taken place…”
Group 2, Micro – Ministry of Health
O.2._201503131230_MEX
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Some participants reported that care providers from
the secretariat of health partially manage knowledge
more efficiently than did social security systems. For
instance, The National Institutes of Speciality (e.g., the
National Institute for Rehabilitation) have a more de-
veloped system for managing and using knowledge than
the regional hospitals of the secretariat of health. We
found that this is a consequence of various people-
related factors.
“…[t]his is all a process and we are all at different
levels and a lot of what can be achieved in each
process can be related to the interest of research
groups intra- or extra-institutional… but we are not
all at the same level… some haven’t started yet.”
(Group 1, O.2._201502251245_MEX)
Organisation-related factors as barriers
Efficient management and use of knowledge is facilitated
if actors effectively use processes and structures in a
healthcare system. But the results of this study show that
knowledge is often inadequately managed at the meso
level. This is less of an issue at macro and micro level.
The formal processes and structures are insufficient to
facilitate efficient management and use of knowledge be-
cause post-market surveillance data is inadequate. Thus,
information flows insufficiently, knowledge spreads poorly,
and there is little synergy created by processes that run in
parallel. Interview participants described organisation-
related factors that, in their view, contributed to the failure
of national organisations to manage knowledge adequately,
especially on a process or structural level, such as the
organisational processes or structures of social security sys-
tems or care providers of the secretariat of health.
Many participants pointed out that current formal pro-
cesses and structures make it difficult to collect adequate
post-market surveillance data because they inadequately
integrate knowledge about clinical procedures.
“… [t]he principal weakness of the Mexican system is
at the post-commercialization…”
(Group 1, O.2._201502261115_MEX)
Clinical data collection starts with clinical procedures
and needs to be established, e.g., a post-market surveil-
lance system. Some interviewees said that current pro-
cesses and structures do not connect the meso and micro
levels well enough; data collection is inconsistent, so clin-
ical procedures do not generate adequate knowledge.
“…[a]part of adverse events there is no intermediate
information available. So there is a lot of information
that we lose… as a surgeon you are very limited with
regards to access information…”
(Group 1, O.2._201503091215_MEX)
“[B]ut you don’t follow up (clinical cases). You know when
you follow up, this is when there is any complication…”
(Group 2, O.2._201503111600_MEX)
Some participants claimed that medical specialists often
have restricted access to information that coordinates
Table 5 Summary of management and role of knowledge
Topic Identified themes
Dimension “people” • Absence of a mutual learning culture specifically for HRMDs.
• Inadequate knowledge sharing culture to manage complaints.
• No sustainable commitment to clinical knowledge-informed quality assurance programmes.
• Need to engage people in generating knowledge.
• Organisations unable to generate knowledge.
• Uncertainty how to apply knowledge correctly
• Failure to identify the relevance of post-market surveillance data.
Dimension “organization” • Absence of structures to improve handling and management of complaints and adverse events
across departments.
• Absence of structures to obtain adequate information of data from clinical procedures.
Dimension “management” • Opportunities to develop strategies that merge the interests of the different sectors to achieve federal
knowledge goals.
• Need for improved exchange of information between federal units and insufficient to create synergies.
• Opportunities to implement strategies that can adequately measure e.g. the clinical performance of MDs.
Dimension “information technology” • Insufficient implementation of electronic patient data collection and records.
• Lack of infrastructure for collecting national post-market surveillance data.
• Need for an application that monitors performance of MDs in clinical use.
Role of knowledge • Rigid evaluation criteria like demand calculation.
• Lack of orthopaedic experts on decision-making committees.
• Importance of lowest acquisition price.
• Feedback loop on performance of HRMD between users and administrators.
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meso level actors from departments like administration or
research and quality. Medical specialists rely on a limited
set of data to perform clinical procedures or research, and
there are no monitoring processes for following up clinical
cases over the long-term.
“[T]hey provide us with some type of report, they
inform us in general about the number of prosthesis
and patients… but we don’t receive more information.”
(Group 1, O.2._201502241600_MEX)
Further, participants noted that formal processes and
structures that intended to improve quality did not allow
actors in a health system to create synergy with other ac-
tors running in parallel. They also noted that these are
poorly coordinated because the health system is frag-
mented and segmented. Creating synergies improve out-
comes of single processes or strategies like national
programmes and initiatives.
“…[t]hey are still duplicating their efforts… but what is
difficult to change is the bureaucratic territory of each
institute and there is no incentive that could motivate
them to focus on a common purpose… an therefore they
make what they can but not always coordinated…”
(Group 1, O.2._201503101730_MEX)
For instance, formal processes and structures for the
management of complaints related to the use of HRMD
at the macro level: The National Commission for Med-
ical Arbitration (CONAMED) receives complaints from
patients about service attention of care providers, and
the Department of Technovigilance of the Federal De-
partment of Health and Human Services of Mexico
(COFEPRIS) also documents HRMD complaints but on
the level of e.g. adverse events (e.g. metal debris cause
damage to bone reaction; bone cement insufficiently at-
taches to cemented implant surface; pelvis cap anchoring
technology leads to early loosening of implant) [39] and
reported by the physician or medical device supplier.
However, CONAMED and COFEPRIS have no pro-
cesses in place to share and mutually learn from these
complaints.
Management-related factors as barriers
Knowledge strategy, goals, and measurement (e.g.,
knowledge control, measurement criteria, performance
indicators) provide direction to actors in a healthcare
system. Actors can then manage and use knowledge ef-
ficiently and follow-up on strategies, thereby increasing
the effectiveness of their strategies and goals. Some
stakeholders felt they were not given adequate
direction. This was moderately prevalent at the meso
level, but rare at the macro and micro levels. Our ana-
lysis revealed several themes where stakeholders related
the failure to manage knowledge adequately to
management-related factors, since these failures were ob-
served in strategies, goals, and measurement of (i) federal
units, (ii) care providers of the secretariat of health, (iii)
social security systems, and (iv) healthcare professionals.
The participants reported that it is difficult to fulfil the
national goals in the health system since the coordinat-
ing role of the ministry of health is weak, particularly in
the relations with the social security organizations and
the health systems in the sovereign states in the country.
Thus, care providers may not apply national strategies
because they are not obliged to.
“…[p]rogrammes are established, they are effused like
documents to be used but rarely there is a control if
these programmes are realized… There is a deficiency
beginning at the central legal level up to the state level
where there are no adequate strategies to implement a
program to improve quality.”
(Group 1, O.2._201503171700_MEX)
Some participants explained that strategies are some-
times based on goals but are still disconnected from
clinical procedures or rely on other data that may not
fully represent clinical needs. For example, in recent
years, many clinical guidelines have been written and in-
troduced. Stakeholders who know clinical procedures
complain that the goal of introducing so many clinical
guidelines took precedence over developing strategies to
benefit clinical procedures and processes.
“[A]nd if we had focused to develop clinical
guidelines for a limited number of diseases and have
made the implementation strategy more carefully
with measurements and incentives we would have
another scenario… Now the problem is big because I
don’t know how the clinical guidelines will be
updated…”
(Group 1, O.2._201503101730_MEX)
Federal units do not have well-established strategies to
effectively collaborate with each other, as seen with
CONAMED and COFEPRIS.
“… [C]OFEPRIS… Consejo de Salubridad General…
Cuadro Basico… CENETEC… and these four federal
entities have been quite disconnected…”
(Group 1, O.2._201503091215_MEX)
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There was a similar problem at the meso level. Depart-
ments for research and quality look at HRMD failures
through the lens of material specification or technology.
They focus strongly on the indications of the standard
list for HRMDs “Cuadro Basico”, but do not seek to gain
knowledge from the observations that orthopaedic spe-
cialists generate during clinical procedures. These obser-
vations might include other types of product failures like
anatomical aspects of HRMDs, steps in inserting or re-
moving a HRMD, or special components of the instru-
ment that cost clinicians a lot of time.
Information technology-related factors as barriers
Infrastructure and applications create the technical en-
vironment where knowledge is managed within and be-
tween the different levels of healthcare delivery.
Information technology is an important aspect to trans-
fer and process knowledge [3]. Some interviewees
pointed out inadequate knowledge management being
moderately prevalent at the meso and micro levels, and
less prevalent at the macro level. Technological support
is less efficient at the meso and micro levels, where ad-
ministrators and healthcare professionals operate. The
problem consists of information being insufficiently col-
lected and analysed. For several themes, interviewees as-
sociated the failure to manage knowledge adequately
with the absence of technological solutions.
Some stakeholders pointed out that current applica-
tions are not set up to run analyses of interest, like de-
termining the performance of HRMDs in use. They said
that there is limited infrastructure for sharing clinical
data with healthcare professionals or other care pro-
viders within the same public sector. Some explained
that insufficient infrastructure and failure to systematise
data makes it hard to merge data from different public
sectors.
“…[T]here are two problems that I can identify: One is
the absence of basic information systems … our
information is in general not systemised.“
(Group 1, O.2._201503101730_MEX)
For instance, CONAMED uses a web-based system to
collect information about clinical incidents, which are
reported mainly by patients. Aligning this system with
databases from the social security systems would in-
crease the knowledge that could be drawn from these
data. A few stakeholders reported that one of the social
security sectors is working with CONAMED to do this.
There are few adequately developed applications that
collect and store patient data. Applications that monitor
the performance of HRMD are incomplete or
unavailable.
“[I]n some institutes … they do have an electronic
health record, but it is another deficiency that our
country was not able so far to consolidate the
electronic health records on national level…”
(Group 1, O.2._201502261200_MEX)
Role of knowledge from clinical procedures and in
relation to procurement of orthopaedic HRMD
Orthopaedic HRMDs are procured in Mexico through
an administrative process that relies on standardized
regulations to consolidate purchase power. These are
mainly based on tender processes that regroup different
purchases to increase purchasing power and negotiate
better prices from suppliers. The results of this study
show that knowledge from clinical procedures is insuffi-
ciently integrated into procurement decision-making.
Many stakeholders thought this was caused by standard-
ized procurement regulations and problems with know-
ledge exchange between orthopaedic specialists and
administrators or between management levels of care
providers. We found a number of themes, which de-
scribed the very small role played by knowledge of clin-
ical procedures.
A number of interviewees indicated that orthopaedic
specialists are insufficiently involved and that procure-
ment applies rigid evaluation criteria like demand calcula-
tion based on consumption history, and conformity
controls based on technical or material specifications.
However, stakeholders are very interested in procurement
decision-making that integrates the orthopaedic specialist.
“[T]hey don’t take into consideration the surgeon to
take decisions because often the administrators decides
and they buy things that no one uses.”
(Group 2, O.2._201503121730_MEX)
Some interviewees claimed that when procurement
did involve medical specialists, they were often not in
orthopaedics or were unfamiliar with local clinical needs.
Hiring of responsible staff that could contribute to im-
proving the outcome of procurement decision-making
was inconsistent.
Other respondents stated that decision-making was
strongly influenced by the lowest acquisition price. In
our first study informants already noted this. Ortho-
paedic specialists attribute their inferior role in decision-
making to the acquisition price factor.
“…[i]t is a straight situation of money, this is the only
thing that really matters…”
Group 2, CP_O.2._201503311600_MEX
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Another theme that some participants emphasized was
the formal complaint management processes. They noted
that these did not influence procurement decision-making
enough because complaints were not well-managed. For
example, a group of orthopaedic specialists repeatedly re-
ceived sub-standard quality of orthopaedic HRMDs, even
after they had submitted formal complaints. They were
eventually able to change their local procurement prac-
tices to incorporate knowledge from clinical procedures
and post-market surveillance data of HRMDs. This
change was only possible because the specialists insisted
on escalating their complaints to upper-level management
in their social security system, over several years. This
situation seems exceptional. According to stakeholders of
other healthcare providers, the problem of receiving sub-
standard quality of HRMDs and services has not been
solved.
“[L]et’s say that I think that these companies can’t
afford to manage the volume of the hospital and for
example the other day I wanted to implant a femoral
cup size 52 but I only had available size 50 and 54
and so I had to implant the cup size 50.”
Group 2, O.2._201503181600_MEX
Opportunities to improve the situation
Based on the first two objectives of this study we
depicted which knowledge-related factors may lead to a
situation of inconsistently generated knowledge of
orthopaedic clinical procedures and in the context of
procurement. The third objective of our study aimed to
identify opportunities that may improve this situation by
drawing on the findings of the previous two objectives
and by asking interviewees what they believe is needed
to improve the situation.
Many factors that we identified during the thematic
analysis are related directly or indirectly to technological
aspects, which we found are insufficiently developed.
“[W]ell, I believe it is a matter of stewardship… of the
ministry of health where clinical evidence should be
regulated, from the clinical guidelines, the eligibility of
goods and their regulation, monitor the clinical
practice and provide feedback; overall, feedback…
regulated for the private and public sector”
Group 1, O.2._201503091215_MEX
“[I]n some institutes, in some hospital centres of
medical third level attention… there, electronical patient
dossiers exist… however, and this is another deficiency, our
country was unable to consolidate them at a national
level, as it was proposed by the previous administration.”
Group 1, O.2._201502261200_MEX
For public procurement in Mexico we believe that
there is an opportunity to develop an action plan how to
improve the management of systems’ knowledge across
all social security institutes and ministry of health. Op-
tions of information technology may provide a basis in
order to improve the intersections that procurement has
with the knowledge environment (areas and activities re-
lating to evidence and knowledge synthesis).
Procurement is an administrative area that is influenced
by four principal aspects: Policy mechanisms and regula-
tions; key procurement actors; degree of procurement
centralization; and, criteria used to make procurement de-
cisions [27]. In Mexico, public procurement practices are
highly standardized and key procurement actors belong to
the meso level and rarely to the micro level. The results of
this study show that opportunities to improve the current
situation were often associated with “key procurement ac-
tors” or “criteria used to make procurement decisions”.
“[T]o improve we have to destroy the chains that limit
the genuine commitment of doctors to look for a
system, an implant of a quality; his decision nowadays
is rather next to financial or administrative decisions.
I believe we have to give greater emphasis to the
doctor who is finally the user of implants…”
Group 2, O.2._201502251340_MEX
“[F]or me, at least in my institute that the technical
advise is taken again into consideration…”
Group 2, O.2._201502271600_MEX
“[T]here should be communication of the directive of
the sector towards the doctors… it should therefore
integrate heads of departments and between them
reach a consensus and a way to define the required
materials to treat patients.
Group 2, O.2._201503131230_MEX
The mechanism of public procurement in Mexico may
not allow to actively integrating users in decision-making
but there are opportunities to better integrate user know-
ledge. For instance, monitoring relevant aspects of clinical
procedures that are important to assure the healthcare
worker and patient safety by modifying the needs assess-
ment strategy in the course of upcoming tenders.
Discussion
In the Mexican Healthcare System and on behalf of the
Ministry of Health many changes have taken place
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especially since 2006, such as comprehensive reforms to
improve the health system [40–42], sectorial health pro-
grammes or research to improve quality across various
dimensions [29, 43–46]. This is an important strength of
the system because it is frequently concerned with situa-
tions lacking the ability to make progress in their
performance.
Based on our findings it was evident that stakeholders
in Mexico recognize that knowledge is an important
resource but they are not able to manage it effectively
and efficiently. The examples provided by the inter-
view participants lead to important factors that trigger
this situation and which we identify as information
technology-related factors. The knowledge-related prob-
lems reported by interviewees focused strongly on “People”
and “Organisation” but are connected to information-
technology. For instance, participants referred to problems
of systematic databases, not using synergies and being
unable connecting the variety of systems’ knowledge.
Without adequate infrastructure and applications to
manage big data across the different healthcare delivery
levels knowledge-related problems summarized in
Table 4 and 5 cannot be solved adequately. In Mexico,
policy makers have already identified the added value of
information technology supporting procurement. For
instance, the introduction of “compranet” [47] as appli-
cation that provides transparency in respect to expendi-
tures and awards of public tenders, and which operates
mainly on the meso and macro level. We did not identify
applications established that are based on a systematic ap-
proach to manage knowledge from clinical practice and
connecting to procurement.
Overall we found that in Mexico the knowledge envir-
onment influences procurement regulations and prac-
tices of orthopaedic HRMDs in the following ways: 1)
deficiencies in the healthcare system’s ability to manage
knowledge of clinical procedures efficiently; and 2) defi-
ciencies in the management of knowledge from clinical
procedures and post-market surveillance data as it directly
relates to procurement. Analysing knowledge-related
factors, guided by considering the four knowledge man-
agement dimensions, lead us understand which factors
trigger ineffective and inefficient knowledge management.
The findings of this study point out knowledge-related op-
portunities for procurement practices of orthopaedic
HRMDs in Mexico.
We found that the ability of procurement administrators
or agents may improve when knowledge of orthopaedic
clinical practices is adequately integrated in decision-
making processes [27]. Procurement administrators or
agents are concerned with providing the right quality of
the purchased products (manage product complexity)
and accompanying services (prevent commercial uncer-
tainty) [48, 49]. Studies focus on knowledge gaps about
buyer-supplier relationships [50] but not with knowledge-
related factors influencing procurement and purchasing of
HRMDs.
In our study we found that factors triggering the inef-
fective and inefficient use of knowledge can be associ-
ated with poorly developed technological solutions at
the level of clinical procedures. We believe that there is
an opportunity in managing knowledge in the field of
orthopaedic HRMDs by adequately applied information
technology solutions. Studies are concerned with health
information management and technology and how it can
be utilized to improve important outcomes and overall
quality of care in different health care settings [51–54].
The interest in knowledge-related topics in healthcare
systems is often focused on clinical informatics to pro-
mote patient care and safety like, for example, clinical
decision-making. In this context, many studies report
about eHealth solutions (managing single and aggregated
health information for healthcare professionals, patients,
and healthcare consumers), and applying it in clinical
decision-making [5, 7, 55, 56] like, for example, the use of
electronic patient dossiers operating at both the clinician
and patient level [57].
Further, managing big data becomes more relevant [58]
and we found that the use of options supporting know-
ledge management in the field of orthopaedic HRMDs by
information technology applications are promising
[54]. In the field of orthopaedics many policy makers
use already approaches of information technology to
guide decision-making. Examples for this are national
arthroplasty registries [59], and approaches that build
on such arthroplasty registries like, for instance the
“Orthopaedic Data Evaluation Panel” (ODEP) in the
UK. ODEP is defined as a supporting decision-making
instrument for procurement. ODEP rates implant sur-
vival data based on clinical information and clinical
evidence. It represents a guideline for procuring ortho-
paedic HRMDs and is established by the National Institute
for Health and Care Excellence of the UK. ODEP rates im-
plant survival data based on clinical information and
clinical evidence level, received from the “National Joint
Registry” (NJR) of the UK. The NJR collects informa-
tion on orthopaedic joint replacement surgery from
clinical procedures, and monitors the performance of
orthopaedic implants. Other healthcare systems like,
for example, Germany and Switzerland, integrate infor-
mation from arthroplasty registries into their quality
agenda [60, 61]. Without using information technology
applications to manage big data it would not be possible
to inform procurement decision-making adequately with
information and knowledge of clinical practice.
We found that knowledge-related factors influencing
procurement practices are not a unique finding for
Mexico and orthopaedic HRMDs. The results of this
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study are primarily relevant for Mexico but may also
give impulsion to other health systems with an increase
of centralized procurement, like for example: Collab-
orative procurement hubs (e.g. United Kingdom), and
national or regional purchasing groups (e.g. France,
Germany) [27, 50, 54].
Limitations and avenues for further research
Our study has several limitations. First, even we have
opted a sampling based on a maximum variation tech-
nique, we did not include (i) a larger number of stake-
holders representing the meso level of different social
security systems, and (ii) patients or representatives from
rehabilitation centres to provide a broader range of atti-
tudes of the micro level. Secondly, our ability to generalize
the findings was limited as we only considered ortho-
paedic HRMDs. Third, attitudes of stakeholders from
other states may differ from those of the State of Mexico
and the Federal District. Fourth, we did not take a formal
knowledge management approach to clearly differentiate,
e.g., between knowledge management systems and infor-
mation systems.
More research is needed to clarify some issues raised
in this study. What programmes could be established to
improve the contribution of clinicians to knowledge
management practices? What do our findings mean for
the national health budget? Answering these questions is
imperative to improving the generation and manage-
ment of knowledge about clinical procedures as it is re-
lated to the procurement of orthopaedic HRMDs in
Mexico.
Conclusions
We believe this is a novel investigation of knowledge-
related factors that influence procurement and clinical
procedures for orthopaedic medical devices in Mexico.
We identified specific aspects of knowledge and related
them to procurement practices, using orthopaedic
HRMDs as our example, and showed how they are re-
lated with clinical practice.
We explored the perceptions of a range of healthcare
actors around the topic of generating and managing
knowledge for improved procurement processes of
orthopaedic devices. We showed that knowledge is an
important resource, identified factors along the dimen-
sions of knowledge management and healthcare delivery
levels that create barriers, and discussed them in the
context of administrative processes. The deficiencies we
identified should motivate researchers to further clarify
the relationship between clinical procedures and admin-
istrative processes in the knowledge environment.
Stakeholders in Mexico recognize that knowledge is an
important resource, but they are not able to manage it
effectively and efficiently. A favourable approach would
be when procurement administrators exchange more
knowledge with orthopaedic specialists who have per-
formed surgical techniques, know the clinical properties
of implants, and are familiar with the services provided
by suppliers (e.g., the condition of instrument sets and
availability of implant type or size), to improve procure-
ment outcome. Without adequate solutions of managing
knowledge for orthopaedic services, procurement pro-
cesses for orthopaedic HRMDs will remain sub-optimal.
Mexico needs versatile solutions for the meso level and
the federal level of the Mexican healthcare system so as
to better analyse information and data from clinical proce-
dures. Many of our findings can be attributed to poorly
developed information technology aspects. Improving op-
tions of managing knowledge by information technology
may positively influence the impact of procurement
decision-making on clinical practice and improve the
healthcare worker and patient safety in the long-term.
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